Pediatric Cancer Clinical Trial Finder
We believe that patients and families should have tools available to help make the search for treatments easier. For that reason, we’ve developed a Pediatric Cancer Clinical Trial Navigator for CAR T-cell therapy and other immunotherapy treatments. Use the filters to display relevant trials. Clicking on a card will allow you to access more detailed information, including contact information, for each clinical trial.
Genetic
Biological
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/cell.png)
Drug
Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia
U.S.
CA,
CO,
MD,
MA,
PA,
WA
Recruiting
Learn More
Genetic
Biological
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/cell.png)
Drug
CAR-20/19-T Cells in Pediatric Patients With Relapsed/Refractory B Cell ALL
U.S.
WI
Not yet Recruiting
Learn More
Genetic
Biological
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/cell.png)
Drug
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/drug.png)
Phase I CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults with Recurrent or Refractory B Cell Malignancies
U.S.
CA
Recruiting
Learn More
Genetic
Biological
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/cell.png)
Drug
Determine Efficacy and Safety of CTL019 in Pediatric Patients With Relapsed and Refractory B-cell ALL (ELIANA)
Canada
Australia
U.S.
CA,
GA,
MI,
MN,
MO,
NC,
OH,
OR,
PA,
TX,
UT,
WI
Europe
Japan
Active, not recruiting
Learn More
Genetic
Biological
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/cell.png)
Drug
Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma
U.S.
PA
Recruiting
Learn More
Genetic
Biological
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/cell.png)
Drug
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/drug.png)
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
U.S.
TN
Recruiting
Learn More
Active, not recruiting
Learn More
Genetic
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/genetic.png)
Biological
Drug
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT (MULTIPRAT)
U.S.
TX
Active, not recruiting
Learn More
Active, not recruiting
Learn More
Genetic
Biological
![Genetic Double Helix](https://emilywhiteheadfoundation.org/wp-content/themes/ewf/img/cell.png)
Drug
Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy (HERCREEM)
U.S.
TX
Completed
Learn More